Filing Details
Odyssey Health, Inc. (OTC:ODYY) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 28, 2026.
The Healthcare company's annual report covers fiscal year 2026.
10k filedOTC:ODYY
Odyssey Health, Inc. (ODYY) Files Annual Report with SEC
Odyssey Health, Inc. (OTC:ODYY) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 28, 2026.
At publication ·
What changed
Odyssey Health, Inc. (OTC:ODYY) · 10k filed
- Form
- 10-K
At a glance
Key takeaways
- Odyssey Health, Inc. (ODYY) filed its 2026 annual report (Form 10-K) with the SEC on October 28, 2026.
- The company's stock trades at $0.01 per share with a market capitalization of $4.0 million.
- The 10-K filing includes detailed financial statements, management discussion and analysis, risk factors, and business segment breakdowns for the full fiscal year.
Market Context
Odyssey Health, Inc.'s stock currently trades at $0.01 with a market capitalization of $4.0M.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For Odyssey Health, Inc. investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for Odyssey Health, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ODYY Stock Page
Frequently Asked Questions
Where can I read ODYY's SEC filings?
Browse all filings on our ODYY SEC filings page.
What types of SEC filings does Odyssey Health, Inc. file?
Public companies like Odyssey Health, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.